Skip to content

Analysis of Pediatric Pancreatitis - APPLE trial

Analysis of Pediatric Pancreatitis (APPLE): a cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN89664974
Enrollment
300
Registered
2015-02-12
Start date
2015-02-15
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pancreatitis Nutritional, Metabolic, Endocrine Acute pancreatitis

Interventions

No interventions

Sponsors

Hungarian Academy of Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Acute pancreatitis 2. Age < 18 years old 3. Presenting at the emergency department of a hospital

Exclusion criteria

Exclusion criteria: Age > 18 years old

Design outcomes

Primary

MeasureTime frame
1. Develop a simple and accurate clinical scoring system to stratify children with acute pancreatitis during the first 6–12 hours of hospitalization according to their risk of a severe disease course: simple data (e.g. medical history, physical examination, laboratory tests and diagnostic imaging ) will be collected, recorded and statistically analyzed to assess their potential correlation with the disease severity 2. Specify the genetic background: mutations in the genes PRSS1, CTRC, CPA1, CFTR and SPINK1 will be sequenced 3. Recognize better the course of the pediatric pancreatitis Data will be analyzed at 3 months.

Countries

Belarus, Bosnia and Herzegovina, Czech Republic, Estonia, Finland, Germany, Hungary, Italy, Latvia, Moldova, Poland, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Spain, Sweden, Türkiye, Ukraine, United States of America

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: May 16, 2026